-
Leveraging Artificial Intelligence to Streamline Study Quality Assessment in Systematic Literature Reviews
Mar 10, 2025, 14:00 PM -
Temporal Trends in Prescription of GLP-1RAs for Weight Loss: Insights From a Five-Year Retrospective Analysis in the US
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Sociodemographic Factors on Patient Perceptions of Chronic Heart Failure Management
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review on Symptom Burden and Impact of Disease on Quality of Life in Patients With Essential Thrombocythemia
Mar 10, 2025, 14:00 PM -
Changes in Respiratory Medication and Antibiotic Use Among Asthma and COPD Individuals During the Pandemic
Mar 10, 2025, 14:00 PM -
Frailty Indices Using Claims Data - Examples from a Hospitalized Medicare Population
Mar 10, 2025, 14:00 PM -
Productivity Loss And Indirect Costs Of Heart Failure: Analysis Of The Brazilian Social Security System
Mar 10, 2025, 14:00 PM -
ICER Thresholds in Cost-Utility Analysis: Assessing Conceptual Relevance and Practical Adequacy for Drug Reimbursement Decision-Making in The US
Mar 10, 2025, 14:00 PM -
Functional, Fatiguability and Quality of Life (QoL) Endpoints for Spinal Muscular Atrophy (SMA) Clinical Trials: Perception by Health Technology Assessment (HTA) Bodies and Regulators and Validation Status
Mar 10, 2025, 14:00 PM -
Treatment Patterns and Efficacy/Safety of the Drugs in HER2+ NSCLC: A Systemic Literature Review
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Intravenous Ferric Carboxy Maltose Versus Iron Sucrose to Treat Anemia in Pregnancy in Indian Context
Mar 10, 2025, 14:00 PM -
Empowering Patients in Observational Research: Leveraging Data Insights for Sustained Engagement and Innovation
Mar 10, 2025, 14:00 PM -
Association Between Guideline Concordant Treatment and Healthcare Resource Utilization and Clinical Outcomes Among Older Adults Newly Diagnosed with Stage III - IV Melanoma
Mar 10, 2025, 14:00 PM -
Geographic Variation in Lower Limb Prosthesis Prescription Disparities Between White and Black Veterans: A Retrospective Cohort Analysis (2010 - 2022)
Mar 10, 2025, 14:00 PM -
Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US
Mar 10, 2025, 14:00 PM -
US Food and Drug Administration Authorizations of Therapeutic Biologics and Biosimilars, 1980-2024
Mar 10, 2025, 14:00 PM -
Key Considerations in the Use of Large Language Models for Data Extraction in Health Economics and Outcomes Research
Mar 10, 2025, 14:00 PM -
US Physician Characteristics Associated With Real-World Evidence Implementation in Oncology Practice
Mar 10, 2025, 14:00 PM -
A European perspective on Health Resource Utilization (HRU) and Cost outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Psychometric Evaluation of the ASCOT-SCT4, a Preference-Based Quality of Life Instrument for Social Care Service Users in Hong Kong: An Application of Item Response Theory
Mar 10, 2025, 14:00 PM